CLEAN ENERGY FUELS CORP (CLNE)

US1844991018 - Common Stock

2.56  +0.03 (+1.19%)

After market: 2.5532 -0.01 (-0.27%)

Fundamental Rating

3

CLNE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 205 industry peers in the Oil, Gas & Consumable Fuels industry. CLNE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, CLNE is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

CLNE had positive earnings in the past year.
In the past year CLNE had a positive cash flow from operations.
CLNE had negative earnings in 4 of the past 5 years.
CLNE had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a Return On Assets value of -5.75%, CLNE is not doing good in the industry: 85.78% of the companies in the same industry are doing better.
CLNE has a worse Return On Equity (-9.88%) than 80.39% of its industry peers.
Industry RankSector Rank
ROA -5.75%
ROE -9.88%
ROIC N/A
ROA(3y)-7.68%
ROA(5y)-4.36%
ROE(3y)-11.43%
ROE(5y)-6.48%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of CLNE (29.73%) is worse than 60.78% of its industry peers.
In the last couple of years the Gross Margin of CLNE has declined.
The Profit Margin and Operating Margin are not available for CLNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.26%
GM growth 5Y-13.03%

4

2. Health

2.1 Basic Checks

CLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLNE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLNE has more shares outstanding
Compared to 1 year ago, CLNE has a worse debt to assets ratio.

2.2 Solvency

CLNE has an Altman-Z score of 0.09. This is a bad value and indicates that CLNE is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.09, CLNE is not doing good in the industry: 72.55% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.37 indicates that CLNE is not too dependend on debt financing.
CLNE has a Debt to Equity ratio (0.37) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z 0.09
ROIC/WACCN/A
WACC8.54%

2.3 Liquidity

A Current Ratio of 3.06 indicates that CLNE has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.06, CLNE belongs to the best of the industry, outperforming 81.86% of the companies in the same industry.
A Quick Ratio of 2.74 indicates that CLNE has no problem at all paying its short term obligations.
CLNE's Quick ratio of 2.74 is amongst the best of the industry. CLNE outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 3.06
Quick Ratio 2.74

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 150.00% over the past year.
The Revenue has decreased by -4.33% in the past year.
The Revenue has been growing slightly by 4.18% on average over the past years.
EPS 1Y (TTM)150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.21%
Revenue 1Y (TTM)-4.33%
Revenue growth 3Y13.38%
Revenue growth 5Y4.18%
Sales Q2Q%9.74%

3.2 Future

The Earnings Per Share is expected to grow by 72.08% on average over the next years. This is a very strong growth
CLNE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.91% yearly.
EPS Next Y63.16%
EPS Next 2Y-29.29%
EPS Next 3Y32.44%
EPS Next 5Y72.08%
Revenue Next Year-3.27%
Revenue Next 2Y-0.82%
Revenue Next 3Y3.81%
Revenue Next 5Y23.91%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 85.33, CLNE can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CLNE is valued a bit more expensive than the industry average as 75.00% of the companies are valued more cheaply.
CLNE is valuated expensively when we compare the Price/Earnings ratio to 27.73, which is the current average of the S&P500 Index.
CLNE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 85.33
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLNE is valued a bit more expensive than 78.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 31.73

4.3 Compensation for Growth

CLNE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CLNE's earnings are expected to grow with 32.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.35
PEG (5Y)N/A
EPS Next 2Y-29.29%
EPS Next 3Y32.44%

0

5. Dividend

5.1 Amount

No dividends for CLNE!.
Industry RankSector Rank
Dividend Yield N/A

CLEAN ENERGY FUELS CORP

NASDAQ:CLNE (12/20/2024, 8:02:40 PM)

After market: 2.5532 -0.01 (-0.27%)

2.56

+0.03 (+1.19%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)N/A N/A
Inst Owners51.6%
Inst Owner Change-2.86%
Ins Owners27.47%
Ins Owner Change0%
Market Cap572.06M
Analysts83.75
Price Target7.11 (177.73%)
Short Float %6.56%
Short Ratio6.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)157.18%
Min EPS beat(2)128.59%
Max EPS beat(2)185.77%
EPS beat(4)4
Avg EPS beat(4)183.34%
Min EPS beat(4)77.37%
Max EPS beat(4)341.62%
EPS beat(8)7
Avg EPS beat(8)110.96%
EPS beat(12)9
Avg EPS beat(12)68.52%
EPS beat(16)10
Avg EPS beat(16)-400.75%
Revenue beat(2)1
Avg Revenue beat(2)-3.87%
Min Revenue beat(2)-9.94%
Max Revenue beat(2)2.21%
Revenue beat(4)2
Avg Revenue beat(4)-1.58%
Min Revenue beat(4)-9.94%
Max Revenue beat(4)2.21%
Revenue beat(8)3
Avg Revenue beat(8)-0.84%
Revenue beat(12)4
Avg Revenue beat(12)-2.14%
Revenue beat(16)7
Avg Revenue beat(16)-7.57%
PT rev (1m)-3.5%
PT rev (3m)-2.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-128.6%
EPS NY rev (1m)7.12%
EPS NY rev (3m)55.16%
Revenue NQ rev (1m)1.63%
Revenue NQ rev (3m)-9.94%
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)0.56%
Valuation
Industry RankSector Rank
PE 85.33
Fwd PE N/A
P/S 1.38
P/FCF N/A
P/OCF 6.67
P/B 0.79
P/tB 0.87
EV/EBITDA 31.73
EPS(TTM)0.03
EY1.17%
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.38
OCFY14.98%
SpS1.85
BVpS3.24
TBVpS2.93
PEG (NY)1.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.75%
ROE -9.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.73%
FCFM N/A
ROA(3y)-7.68%
ROA(5y)-4.36%
ROE(3y)-11.43%
ROE(5y)-6.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.26%
GM growth 5Y-13.03%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA 18.29
Cap/Depr 218.88%
Cap/Sales 23.57%
Interest Coverage N/A
Cash Conversion 590.7%
Profit Quality N/A
Current Ratio 3.06
Quick Ratio 2.74
Altman-Z 0.09
F-Score5
WACC8.54%
ROIC/WACCN/A
Cap/Depr(3y)142.46%
Cap/Depr(5y)101.96%
Cap/Sales(3y)17.52%
Cap/Sales(5y)13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.21%
EPS Next Y63.16%
EPS Next 2Y-29.29%
EPS Next 3Y32.44%
EPS Next 5Y72.08%
Revenue 1Y (TTM)-4.33%
Revenue growth 3Y13.38%
Revenue growth 5Y4.18%
Sales Q2Q%9.74%
Revenue Next Year-3.27%
Revenue Next 2Y-0.82%
Revenue Next 3Y3.81%
Revenue Next 5Y23.91%
EBIT growth 1Y62.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year205.07%
EBIT Next 3Y52.83%
EBIT Next 5Y42.77%
FCF growth 1Y-362.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y113.26%
OCF growth 3Y-10.49%
OCF growth 5Y2.88%